Identfication of Potent LXRβ-Selective Agonists without LXRα Activation by In Silico Approaches

Activating Liver X receptors (LXRs) represents a promising therapeutic option for dyslipidemia. However, activating LXRα may cause undesired lipogenic effects. Discovery of highly LXRβ-selective agonists without LXRα activation were indispensable for dyslipidemia. In this study, in...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Meimei Chen, Fafu Yang, Jie Kang, Huijuan Gan, Xuemei Yang, Xinmei Lai, Yuxing Gao
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2018-06-01
Colecção:	Molecules
Assuntos:	LXRβ-selective agonists QSAR modeling molecular docking Kohonen
Acesso em linha:	http://www.mdpi.com/1420-3049/23/6/1349
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!